Trials and tribulations associated with angina and traditional therapeutic approaches

Clinical Cardiology

Volumn 30, Issue SUPPL., 2007, Pages I-16-I-24

  Deedwania, Prakash C ^a,b,c   Carbajal, Enrique V ^a   Bobba, Vishnu R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ACE; ACIP; ACME; ACTION; AVERT; Beta blockers; CASS; ECSS; MASS; MERLIN; Nitrates; Perindopril; PTCA; RCT; RITA 2; SAGE; SCRIP; TIME; VACSS

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIFEDIPINE; NITRIC ACID DERIVATIVE; PERINDOPRIL; PLACEBO; PROPRANOLOL; RAMIPRIL; RANOLAZINE;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INHIBITION; DRUG MECHANISM; EXERCISE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SODIUM CELL LEVEL; SODIUM CURRENT; STABLE ANGINA PECTORIS; STENOSIS; SURVIVAL; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 33847053186     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20049     Document Type: Review

References (50)

1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, et al.: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002
2. Fox K, Garcia MA, Ardissino D, Morais J, Zamorano JL, et al.: Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27(11):1341-1381
3. Holubkov R, Laskey WK, Haviland A, Slater JC, Bourassa MG, et al.: NHLBI Dynamic Registry. Registry Investigators. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. Am Heart J 2002;144:826-833
4. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, et al.: History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003;145:493-499
5. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 2005;352(24):2524-2533
6. Abrams J, Thadani U. Therapy of stable angina pectoris: the uncomplicated patient. Circulation 2005;112:e255-e259
7. Opie LH, Commerford PJ, Gersh BJ. Controversies in stable coronary artery disease. Lancet 2006;367:69-78
8. Reiter MJ. Cardiovascular drug class specificity: beta-blockers. Prog Cardiovasc Dis 2004;47(1):11-33
9. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, et al.: The Atenolol Silent Ischemia Study (ASIST). Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. Circulation 1994;90:762-768
10. Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, et al.: A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet 2004;364:849-857
11. Takaro T, Hultgren HN, Detre KM, participants in the VA cooperative study. VA cooperative study of coronary arterial surgery. II. Left main disease. Circulation 1975;52(Suppl 2):143
12. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 1976;54(Suppl 6):III107-III117
13. Detre K, The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;311:1333-1339
14. Peduzzi P, Kamina A, Detre K, The VA coronary artery bypass surgery cooperative study group. Twenty-two-year follow-up in the VA cooperative study of coronary artery bypass surgery for stable angina. Am J Cardiol 1998;81:1393-1399
15. Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, et al.: Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 1982;66:14-22
16. Murphy M, Hultgren H, Detre K, Thomsen J, Takaro T, Participants of the Veterans Administration cooperative study. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med 1977;297:621-627
17. The VA coronary artery bypass surgery cooperative study group. 18-year follow up in the Veterans Affairs cooperative study of coronary bypass surgery for stable angina. Circulation 1992;86:I21-I30
18. European Coronary Surgery Study Group. Coronary artery bypass surgery in stable angina pectoris: survival at two years. Lancet 1979;1:889-893
19. Varnauskas E. Twelve-year follow-up of survival in the randomized European coronary surgery study. N Engl J Med 1988;319:332-337
20. Second interim report by the European coronary surgery Study Group. Prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1980;2:491-495
21. European coronary surgery study group. Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: a progress report on survival. Circulation 1982;65:67-71
22. European Coronary Surgery Study Group. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-1180
23. Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. Circulation 1985;72(6 Pt 2):V90-101
24. The principal investigators of CASS and their associates. The national heart, lung and blood institute coronary artery surgery study (CASS) Circulation 1981;63(Suppl 1):1-1
25. Fisher L. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med 1984;310:750-758
26. Killip T, Passainani E, Davis K. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985;72(6 Pt 2):V102-V109
27. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, et al.: Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990;82:1629-1646
28. Fisher L. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983;68:939-950
29. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, et al.: The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26(7):1600-1605
30. Hueb WA, Soares PR, Almeida De Oliveira S, Arie S, Cardoso RH et al.: Five-year follow-up of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation l999;100(Suppl 19):II107-II113
31. The ACIP investigators. Asymptomatic cardiac ischemia pilot study (ACIP). Am J Cardiol 1992;70:744
32. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, et al.: The ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995;26:594-605
33. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, et al.: The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004;43(10):1743-1751
34. Spargias KS, Cokkinos DV. Medical versus interventional management of stable angina. Coron Artery Dis 2004;15(Suppl 1): S5-S10
35. Parisi AF, Folland ED, Hartigan P, Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326(1):10-16
36. The TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 2001;358:951-957
37. Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, et al.: Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. One year results of the randomized TIME trial. JAMA 2003;289:1117-1123
38. Pocock S. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-68
39. Henderson R, Pocock S, Clayton T, Knight R, Fox K, et al.: The Second Randomized Intervention Treatment of Angina (RITA-2). Trial Participants Seven-Year Outcome in the RITA-2 Trial: Coronary Angioplasty versus Medical Therapy. J Am Coll Cardiol 2003;42:1161-1170
40. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111:2906-2912
41. The heart outcomes prevention evaluation study investigators. Effects of an angiotension-converting-enzyme inhibitor, Ramipril on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153
42. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-88
43. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD. Angiotensin- converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 2006;47:1576-1583
44. Scandinavian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389
45. Schwartz G, Olsson A, Ezekowitz M, Ganz P, Oliver M, et al.: the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial. JAMA 2001;285:1711-1718
46. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, et al.: Atorvastatin versus Revascularization Treatment Investigators. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341:70-76
47. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, et al.: Vascular Basis Study Group. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation 2005;111:1747-1755
48. Deedwania PC. Study Assessing Goals in the Elderly steering committee and investigators. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Am Heart J 2004;148:1053-1059
49. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, et al.: Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004;109(11):1371-1378
50. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, et al.: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89(3):975-990